Kiora Pharmaceuticals, Inc. (KPRX)

Latest News

View All News

February 19, 2026 8:30 AM EST

Kiora Pharmaceuticals to Present at Oppenheimer's 36th Annual Healthcare Life Sciences Conference

Jan 27, 2026 7:00 am EST

Retinal Disease Expert Dr. Taiji Sakamoto Joins Kiora Pharmaceuticals' Scientific Advisory Board

Dec 1, 2025 6:45 am EST

Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds

Nov 7, 2025 6:00 am EST

Kiora Pharmaceuticals Reports Third Quarter 2025 Results; Company Advances Pipeline with Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases

View All News

Company Overview

Kiora Pharmaceuticals (NASDAQ: KPRX) is a clinical-stage biopharmaceutical company developing advanced treatments for retinal disease. Our strategy is to target critical pathways underlying eye disease with innovative small molecules to preserve, slow, or restore vision loss.

View Executive Team

Latest Financial Results

Q3 2025

Quarter Ended Sep 30, 2025

View All Financial Results

Earnings Release

10-Q XBRL Zip

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2024

View 10-K

IR Contacts

Headquarters

Kiora Pharmaceuticals, Inc.
169 Saxony Rd
Suite 212
Encinitas, CA 92024

Investor Relations

investors@kiorapharma.com

Investor Relations

Oppenheimer’s 36th Annual Healthcare Life Sciences Conference

Latest News

Company Overview

Latest Financial Results

Q3 2025

Latest Annual Filing

Stock Snapshot

IR Contacts

Headquarters

Investor Relations

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Latest News

Email Alerts

Company Overview

Latest Financial Results

Q3 2025

Latest Annual Filing

Stock Snapshot

IR Contacts

Headquarters

Investor Relations